Gonadorelin information

Gonadorelin
Clinical data
Trade names	Factrel, HRF, Kryptocur, Lutrelef, Lutrepulse, Relefact, others
Other names	Abbott 41070; AY-24031; Hoe-471; RU-19847
Routes of; administration	intravenous, subcutaneous
Drug class	GnRH analogue; GnRH agonist; Progonadotropin
ATC code	H01CA01 (WHO) ; V04CM01 (WHO); QH01CA01 (WHO); QV04CM01 (WHO);
Legal status
Legal status	CA: ℞-only;
Pharmacokinetic data
Metabolism	Hydrolysis
Elimination half-life	10–40 minutes
Identifiers
	IUPAC name (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;
CAS Number	33515-09-2 ; 71447-49-9 (diacetate); 51952-41-1 (hydrochloride);
PubChem CID	638793;
DrugBank	DB00644;
ChemSpider	33562;
UNII	9O7312W37G;
KEGG	C07607;
ChEBI	CHEBI:5520;
ChEMBL	ChEMBL1007;
CompTox Dashboard (EPA)	DTXSID20873490 ;
ECHA InfoCard	100.046.852
Chemical and physical data
Formula	C55H75N17O13
Molar mass	1182.311 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6;
	InChI InChI=1S/C55H75N17O13/c1-29(2)19-38(49(80)67-37(9-5-17-60-55(57)58)54(85)72-18-6-10-43(72)53(84)62-25-44(56)75)66-46(77)26-63-47(78)39(20-30-11-13-33(74)14-12-30)68-52(83)42(27-73)71-50(81)40(21-31-23-61-35-8-4-3-7-34(31)35)69-51(82)41(22-32-24-59-28-64-32)70-48(79)36-15-16-45(76)65-36/h3-4,7-8,11-14,23-24,28-29,36-43,61,73-74H,5-6,9-10,15-22,25-27H2,1-2H3,(H2,56,75)(H,59,64)(H,62,84)(H,63,78)(H,65,76)(H,66,77)(H,67,80)(H,68,83)(H,69,82)(H,70,79)(H,71,81)(H4,57,58,60)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1; Key:XLXSAKCOAKORKW-AQJXLSMYSA-N;

Gonadorelin is a gonadotropin-releasing hormone agonist (GnRH agonist) which is used in fertility medicine and to treat amenorrhea and hypogonadism.^[2]^[3]^[4]^[5]^[6]^[7] It is also used in veterinary medicine.^[3]^[5] The medication is a form of the endogenous GnRH and is identical to it in chemical structure.^[2]^[3]^[5]^[7] It is given by injection into a blood vessel or fat or as a nasal spray.^[5]^[1]^[7]

^ ^a ^b ^c ^d "Gonadorelin".
^ ^a ^b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 745–. ISBN 978-1-4757-2085-3.
^ ^a ^b ^c Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 499–. ISBN 978-3-88763-075-1.
^ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 136–. ISBN 978-94-011-4439-1.
^ ^a ^b ^c ^d "Gonadorelin injectable Uses, Side Effects & Warnings".
^ Shao WM, Bai WJ, Chen YM, Liu L, Wang YJ (August 2014). "[Micropump infusion of gonadorelin in the treatment of hypogonadotropic hypogonadism in patients with pituitary stalk interruption syndrome: cases analysis and literature review]". Beijing da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences (in Chinese). 46 (4): 642–645. PMID 25131486.
^ ^a ^b ^c Köhn FM, Schill WB (17 July 2017). "Hormone Substitution in Male Infertility". In Allahbadia GN, Chawla MM, Das RB, Garcia EV, Gandhi G, Merchant R (eds.). The Art & Science of Assisted Reproductive Techniques (ART). JP Medical Ltd. pp. 731–. ISBN 978-93-86322-82-1.

[DrugBank-1] "Gonadorelin".

[Elks2014-2] Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 745–. ISBN 978-1-4757-2085-3.

[IndexNominum2000-3] Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 499–. ISBN 978-3-88763-075-1.

[MortonHall2012-4] Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 136–. ISBN 978-94-011-4439-1.

[Drugs.com-5] "Gonadorelin injectable Uses, Side Effects & Warnings".

[pmid25131486-6] Shao WM, Bai WJ, Chen YM, Liu L, Wang YJ (August 2014). "[Micropump infusion of gonadorelin in the treatment of hypogonadotropic hypogonadism in patients with pituitary stalk interruption syndrome: cases analysis and literature review]". Beijing da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences (in Chinese). 46 (4): 642–645. PMID 25131486.

[AllahbadiaChawla2017-7] Köhn FM, Schill WB (17 July 2017). "Hormone Substitution in Male Infertility". In Allahbadia GN, Chawla MM, Das RB, Garcia EV, Gandhi G, Merchant R (eds.). The Art & Science of Assisted Reproductive Techniques (ART). JP Medical Ltd. pp. 731–. ISBN 978-93-86322-82-1.

Gonadorelin information

and 25 Related for: Gonadorelin information

Gonadorelin

Estrous cycle

Triptorelin

Medication

Estrogen

Finasteride

Luteinizing hormone

Ferring Pharmaceuticals

Trenbolone acetate

Androgen

Metandienone

ATC code V04

Hormone replacement therapy

Feminizing hormone therapy

Trenbolone

Human chorionic gonadotropin

Aromatase inhibitor

Anastrozole

Goserelin

Gonadotropin preparations

Oxandrolone

Estradiol valerate

Oxymetholone

Transgender hormone therapy

Menotropin